| alpelisib based treatment | buparlisib based treatment |
| alpelisib plus letrozole | buparlisib plus letrozole |
la/mBC - HR positive - (neo)adjuvant (NA) 3 | | |
la/mBC - HR positive - NA - PIK3CA mutant | | |
Comparator:
vs letrozole;
Risk of bias:
low;
some concerns;
high;
NA;